Clinical Trials Study
Prediction of the effect on antihyperglycaemic action of sitagliptin by plasma active form glucagon-like peptide-1
World J Diabetes
7(11):230-238.
Published online Jun 10, 2016.
doi: 10.4239/wjd.v7.i11.230
Abstract (1139)
|
Core Tip (971)
|
Full Article (HTML) (3577)
|
Figures (1-3) (158)
|
Tables (1-2) (238)
|
Full Article (PDF)-1110K (716)
|
Audio-2311K (16)
|
Peer-Review Report-107K (241)
|
Answering Reviewers-180K (228)
|
Received: 01/21/2016
|
Revised: 03/12/2016
|
Accepted: 04/22/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (15264)
|
Similar Articles (0)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letters To The Editor
World J Diabetes
7(11):239-242.
Published online Jun 10, 2016.
doi: 10.4239/wjd.v7.i11.239
Abstract (1059)
|
Core Tip (879)
|
Full Article (HTML) (2822)
|
Full Article (PDF)-719K (660)
|
Audio-822K (15)
|
Peer-Review Report-120K (195)
|
Answering Reviewers-8K (141)
|
Received: 01/31/2016
|
Revised: 03/06/2016
|
Accepted: 03/25/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (9515)
|
Similar Articles (0)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open